Since coming into force in July 2012, the new European Pharmacovigilance Legislation has led companies to re-evaluate their safety quality systems and the key skills needed within their existing Drug Safety and Pharmacovigilance teams. To achieve global harmonisation and ensure transparency of safety data, companies have sought to recruit candidates with experience across quality review, CAPA management, PSMF maintenance, audit preparation and inspection readiness. Throughout 2013 AXESS has seen an increase in the demand for candidates with these skills at all levels from Pharmacovigilance Compliance Associates and Assistants to GPvP Auditors and QPPVs. With implementation still on-going, we expect this trend to continue with some companies looking to develop new dedicated teams to meet the challenge head on! For further information, please contact our Drug Safety and Pharmacovigilance Specialist, Christian Simon.